ArticleOrphanet journal of rare diseases2025
Machine learning identifies lipid-associated genes and constructs diagnostic and prognostic models for idiopathic pulmonary fibrosis.
Article in Orphanet journal of rare diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- A systematic review of artificial intelligence-based diagnosis models for idiopathic pulmonary fibrosis.Journal of thoracic disease · 2026Review
- Integrative analysis and experimental validation of dioxin-interacting genes reveal diagnostic and prognostic biomarkers in lung adenocarcinoma.Clinical and experimental medicine · 2026Article
- Identification of diagnostic and prognostic phospholipid biomarkers in idiopathic pulmonary fibrosis via machine learning and in vivo validation.Human genomics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveEmerging evidence suggests a potential relationship between lipid metabolism and idiopathic pulmonary fibrosis (IPF). This study aimed to identify lipid-related genes implicated in IPF pathogenesis.
methodsLipid-associated genes were retrieved from the GeneCards database and analyzed using unsupervised consensus clustering to classify IPF samples. Weighted gene co-expression network analysis (WGCNA) was performed on the identified clusters to determine core modules and hub genes associated with IPF. Machine learning algorithms were applied to these hub genes to construct diagnostic and prognostic models, which were validated across multiple datasets. Single-cell sequencing was used to investigate the distribution of potential pathogenic genes, and their functional roles were further validated through cellular experiments.
resultsTwo distinct clusters were identified, showing significant differences in lung function parameters and fibrosis-related gene expression. WGCNA revealed that the blue module was strongly associated with IPF and served as the core module. Genes from this module were used to construct diagnostic and prognostic models, which demonstrated strong predictive performance across multiple validation datasets. Single-cell sequencing revealed that KLF4 was highly expressed in lung epithelial cells. Functional assays indicated that knockdown of KLF4 did not affect the proliferation of human alveolar type II epithelial cells but significantly enhanced their migratory capacity, thereby promoting the fibrotic process.
conclusionThis study successfully constructed lipid-related diagnostic and prognostic models for IPF and identified KLF4 as a potential causative gene. These findings provide a foundation for further exploration of lipid metabolism in IPF pathogenesis and potential therapeutic strategies targeting KLF4.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.